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With the recognition that human infection with Coxsackie (C) viruses may 
be a  relatively common occurrence, it is important to establish methods for 
determining the  immunological reactions of  this group  of agents.  Published 
work from other laboratories as well as our own has indicated that these agents 
produce serological responses similar to those of other viruses. Thus tests for 
neutralizing (1-5)  and complement-fixing antibodies (4-8) have already been 
adapted to these newly discovered agents, but the details of the mechanics of 
these tests and their reliability  have not as yet been described. It is the purpose 
of this series of three papers to describe in some detail immunological  reactions 
of the C viruses. The first and present paper deals with the neutralization test, 
the second (9) with the complement fixation test, and the third (10) with cross- 
protection tests. 
Materials and Methods 
Virus Suspensions.--Various strains  of C virus, isolated from patients,  sewage, or flies~ 
were employed usually as muscle-bone suspensions of infected mice. Mice used for production 
of virus were inoculated within 48 hours of birth either intraperitoneaUy or subcutaneously, 
and subsequently sacrificed on the 1st day of illness. Dead mice  were discarded and never in- 
cluded in the harvest. In order to accumulate sufficient numbers for harvest, sick mice were 
etherized and stored frozen at --20°C. These mice were later thawed, washed with ether, and 
then the head, hands, feet, viscera, and skin removed. The carcasses were again washed with 
ether and then blended for a few minutes with cold water to make a 10 per cent suspension. 
The suspension was centrifuged at 2500 R.P.~. for 10 minutes and the supernate distributed 
in corked or screw-capped tubes and stored at -20°C. Before use a sample tube was thawed, 
and centrifuged again at 2500 R.P.~. for 5 minutes. 
In a few early experiments, brains were used as a source of virus, but this tissue was aban- 
doned in favor of muscle-bone when the latter was found to contain higher concentrations of 
the virus. 
Although no demonstrable protection of the virus could be detected when 1 or 10 per cent 
normal horse serum was used as a diluent rather than water or saline, 1 per cent horse serum 
was generaily used as a diluent for virus. In making the first dilution to 10  -2 concentration of 
infected tissue, a solution containing 20,000 units of penicil/in and 100 nag. of streptomycin 
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per ml. was added to the diluent, so that the 10  .2 virus suspension contained I000 units of 
penicillin and 5 mg. of streptomycin per rnl. 
Serum.--Human sera were usually frozen at -20°C. soon after collection; although a few 
samples were kept at 2°C.  without any observed deleterious effect on the antibody. These 
were obtained from normal people, or as paired samples from patients. 
Hyperimmune sera were prepared in 2- to 4-week-old albino mice by intraperitoneal inocu- 
lation with I0 per cent suspension of infected murine muscle-bone (or in some instances in- 
fected brain). The recommended course was 6 inoculations consisting of 0.I  ml. each twice 
weekly for 3 weeks. Mice were bled by cardiac puncture 8 to 10 days later. Booster inocula- 
tions were given about every 4 or 5 weeks followed by a serum harvest in 8 to 10 days. A simi- 
lar course was used for preparing serum in hamsters except that infected baby hamster tissue 
was used as the vaccine. 
Monkeys belonging to the following species were used, and all responded with satisfactory 
antibody development when subjected to the indicated course of vaccination: rhesus (Macaca 
mulatta), cynomolgus (Macaca irus, Macaca eynomolgus), green (Cercopithecus aethiops saba- 
eus),  and sooty mangabey (Cercocebus fuliginosus).  However,  following oral administration 
of virus, eynomolgus monkeys responded preferentially (11). With these animals a  series of 
3 to 4 weekly inoculations (each being 2 to 5 ml. of 10  -1 infected murine tissues) were per- 
formed  dividing  each  inoculum  intraperitoneally,  intramuscularly,  and  intracutaneously. 
Animals were given booster inoculations at intervals of 4 to 6 weeks. Serum was collected 8 
to 10 days after vaccination. All animal sera were stored frozen. 
Method of Carrying Out the Test.--In all instances, serum dilutions (made with saline or 
1 per cent horse serum as diluent) were added to the test tubes (I0  X  75 ram.) before the 
addition of virus. The volumes used were 0.2 ml. of each reagent, which were well shaken 
following their mixture. Incubation was varied as indicated, although the standard test now 
in use employs a period of 1 hour at room temperature. 
Test Mice.--Newborn animals in groups of 8 to 1 mother were used. These animals were 
usually less than 24 hours and almost never more than 48 hours old. Pregnant albino mice 
(and on occasion "chocolate" mice) were obtained from four different dealers, and no apparent 
difference in susceptibility of their young was noticed. The young from several mothers were 
often mixed and redistributed at random with 8 mice put in the care of each mother. Following 
inoculation of the serum-virus mixtures, mice were observed daily for 10 to 14 days. Virulent 
strains of the Texas type have short incubation periods and such tests can be terminated safely 
by the 10th day. Mice which died within 2 days of the inoculation and mice which disappeared 
(cannibalism) were not included in the tabulations. Groups of mice in which all died without 
signs of paralysis being observed in any, were considered unsatisfactory and tests performed 
with such groups were repeated. 
Mice were inoculated with 0.02 ml. either intraperitoneally or subcutaneously (between 
the shoulders where the skin is loose). It is felt that the latter route is more satisfactory from 
the standpoint of less leakage of the inoculum. 
Calculation of Results.--The Reed-Muench method was used to calculate all 50 per cent 
end-points, and was used in computing the neutralization index when varying doses of virus 
were employed. The neutralization index equals the difference in titer between that in the 
presence of control normal horse serum and the test serum. 
The results of serum neutralization tests with varying dilutions of serum against a  fixed 
dose of virus (about 100 IDs0) were generally, for a single dilution'of serum, either all-or-none 
neutralization. Serum titers are therefore given as the greatest serum dilution tested which 
neutralized the virus. 
EXPERIMENTAL 
Stability of the  Virus.--Earfier  results in which four strains  (Texas-I,  High 
Point,  Conn.-5,  Ohio-l)  in 50 per  cent  glycerol were  found  to  survive a  trip JOSEPH  L.  MELNICK  AND  NADA  LEDINKO  465 
to Sweden at "room"  temperature gave some indication of the stability of the 
C  viruses. To compare the stability under different temperatures the following 
experiments were carried out. 
Brains and muscle were harvested from infected mice (Conn.-5, High Point, and Texas-I 
strains). Portions from each mouse were cut into small pieces and placed in 50 per cent glyc- 
erol. The remainder was ground with water to make a 10 per cent suspension. Part of this was 
added to an equal volume of undiluted normal monkey serum, and part was frozen without 
TABLE I 
Stability  of C Viruses at 25  °, go, and -20  ° 
Negative log of IDso 
Strain 
Conn.-5  m6 * 
Hi.Pt. m7 
Texas-I m5 
D~s 
0 
6 
26 
421 
0 
9 
56 
427 
0 
15 
70 
428 
Infected mouse brain 
50 per cent  i  50 per cent 
glycerol  I  serum 
25*  2* 
5.0  5.0 
>3.0  4.0,  J 
1.7  I 
3.o i 
5.4  5.4 
>4.0 >5.01>3.{ 
0 
4.7 
>3.0 
0  0 
25* 
5.0 
2.9 
2.1 
5.4 
>3.0 
3.9>1.0 
4.7  4.7 
4.3i>3.0 
2.2 
2 o 
5.0 
>3.0 
5.4 
>4.0 
>2.0 
4.7 
5.3 
!  Wster 
--20 ° 
5.0 
5.0 
5.4 
5.5 
Infected mouse muscle 
50per cent 
glycerol 
25 °  2 ° 
5.8  5.8 
4.0  5.3 
3.3 
5.0 
7.5 
>5.0 >6.0 
6.9 
8.0  8.0 
>3.0 >7.0 
6.5 
50 serumPer  cent  WateJ 
4.7 
4.5 
7.5 
2.6 
4.0 
25 °  2 ° 
I 
5.8  5.8 i 
>2.0  5.2 i 
3.1 
7.5  7.5j 
>3.0 >5.01 
1.7 >3.0] 
8.0  8.0! 
>4.0 >7.0 
>1.0 
--20* 
5A 
6.( 
7.( 
8.( 
7.~ 
* me indicates the 6th passage of the strain in mice. 
addition of serum at --20°C. Tubes containing the infected tissue in glycerol and in serum 
were stored at 2°C. and some at 25°C. and aliquots removed for titration at intervals ~hown 
in Table I. 
The virus was found to be stable and retain its titer for several months when 
frozen at -20°C.  When a  virus-rich tissue such as muscle was used, virus was 
still present when stored at 25°C. for 70 days, although the titer decreased by 
several logs. In glycerol at 2 ° ,  the virus, particularly in fragments of infected 
muscle, decreased only slightly in titer when stored for over 1 year. For work 
with viruses of known titer, it is now our practice to make up a  large batch of 
virus suspension  as  10 per  cent  suspension  of  carcass,  distribute it in  1  ml. 
amounts,  and freeze these tubes at --20°C. until needed. 
Effect of Time,  Temperature,  and  Diluent  on  Virus  Titration  End-Points.- 
To  determine the  effect  of time,  temperature,  and  diluent  on  the  end-point 466  IMMUNOLOGICAL  REACTIONS  OF  COXSACKIE  VIRUSES.  I 
of a  virus  titration,  the  High  Point  strain  (9th  mouse passage)  was  diluted 
both in saline,  and in normal, inactivated  10 per cent horse serum to give the 
following dilutions:  10  -e,  10  --7, and l0  s. Aliquots of these dilutions were kept 
(a) at room temperature for 1 hour; (b) at 37°C. for 2 hours; (c)  at room tem- 
perature  for  1 hour,  followed by incubation at 4°C.  for 20 hours;  and  (d)  at 
room temperature  for 1 hour, followed by incubation at -20°C. for 96 hours. 
The results shown in Table II indicate that the virus is stable in dilute suspen- 
sions  (10  -6 and  10  -7) under all the conditions tested.  The use of either saline 
or 10 per cent normal horse serum gave comparable virus titers. Similar results 
have been obtained with several strains. 
TABLE II 
Effect of Time, l"emperature, and Diluent upon Virus Titrations 
Concentration oi Hi.Pt. virus diluted  Concentration  of Hi. 1Dt. virus 
in saline  diluted in lO per cent normal 
horse serum 
Temperature  Time 
Room 
37  ° 
4 o 
--20 ° 
/Ir$. 
1 
2 
20* 
96* 
101  10  ~ 
8/8 (3)~ 4/6(2) 
71843)  619(s) 
6/8(4)  2/642) 
8/8(8)  6/8(2) 
Titer 
Negative 
10s  log of 
ID~ 
1/8(0)  7.3 
7.2 
6.5 
7.3 
I 
10"I  I0  ~  I0  ~ 
6/8(4)  3/8(0)  0/6 
8/80)  4/8(2) 
Titer 
Negative 
log of 
ID~ 
6.6 
7.0 
* Prior incubation  at room temperature  for 1 hour. 
Denominator indicates number of mice inoculated, and numerator,  mice which succumb 
to disease with paralysis and/or death. The number in parenthesis indicates mice of the group 
with observed paralysis. 
Effect  of Time  and  TemPerature  on Serum Neutralization End-Points.--Be- 
cause the time necessary to inoculate a large series makes it impossible to hold 
each virus-serum mixture for the same period of time, it was important to de- 
termine to what extent this variable influences the neutralization test. 
The effect of time and temperature  on serum neutralization  end-points was investigated 
by incubating  aliquots of various dilutions of 3 immune sera with their homologous viruses 
(100 ID60 doses of each were used) under the following conditions: (a) at room temperature 
for 10 minutes; (b) at room temperature for 1 hour; (c) at 37°C. for 2 hours; 4d) at room tem- 
perature  for 1 hour, followed by storage at --20°C. for 4 days; and (e) at room temperature 
for 1 hour followed by storage at -20°C. for 14 days. 
From the results of Table III, it is seen that human serum (NC-77B) heated 
at 56°C. for 30 minutes,  and unheated  chimpanzee serum  (Becky October 4, 
1949)  gave the  same serum  end-points  (the maximum  dilution  to give com- 
plete protection)  when incubated at room temperature for 10 minutes as when 3OSEPH  L. MELNICK  AND  NADA  LEDINKO  467 
incubated at room temperature for 1 hour, followed by incubation at -20°C. 
for 4 days. The Easton-20 acute and convalescent serum end-points were the 
same when aliquots were incubated at room temperature for I  hour, and at 
room temperature for I  hour followed by incubation at  -20°C. for 14 days. 
Thus,  the  serum  neutralization  end-points  were  the  same,  when  the  same 
serum was compared under varying conditions of incubation. A similar pattern 
was obtained with other strains, in which the incubation period was allowed 
to vary between 25 minutes and 3 hours at room temperature. These experi- 
ments illustrate the fact that neutralized virus mixtures can be stored and tested 
at a later date to yield the same results as freshly mixed serum and virus. At 
the time of carrying out a neutralization test, an aliquot of each virus-serum 
TABLE  TIT 
E.ffec¢ of Time and Tamperalure on Serum Neutralizalion Tiler 
Room 
Room 
37" 
--20  ° 
--20  ° 
Human serum NC-?TB* 
(heated at 56" for 30 rain.) 
o/8 z/6(o) 7/7(31  lO rain. 
1hr.  0/5[ Inc, [717(I) 
2  hrs.  019  015  ISlS(31 
4 day§  01812/6(0)1717(31 
14 days§ 
I  Chimpanzee Becky 
(10/4/49)* (unheated, 
post C virus infection) 
lOO 1/8(o) 
>10  Inc. 
! 1oo 2/8(o) 
lOOlo/8 
s 
1/9(ol  ~/s(s)  100  I 
017  l/S (1)  100 I 
0/6  8/8(3)  loo 
0/7  Is/s(3)  1oo  / 
Easton-20 serums 
Acute $¢rum 
7) Us(7)]<I, 
7(6)  ~/s(6)1<14 
Convalescent serum 
/ 
o/  ~/  o)  0/81>250 
f 
o/  ~/8  0/81>250 
Inc. -  incomplete test. Mice did not survive 2 days after inoculation. 
* 100 ID~o Hi.Pt. strain added. 
100 ID~ Eastoa-2  strain added, 
§ Held at room temperature for 1 hour before being frozen. 
mixture may be frozen away to allow for the replacement of those groups of 
mice which fail to survive for 2 days after inoculation, or which turn out to be 
unsatisfactory for some other reason. 
When  the neutralization index is obtained by mixing varying dilutions of 
virus with an undiluted serum, the virus in the mixture remains neutralized 
when frozen at -20°C. for several days. In the presence of normal serum, the 
virus titer is not affected by the freezing. A typical experiment yielding these 
results,  which are shown in Table IV,  follows:-- 
The ~-IF  1943 strain  (2nd mouse passage)  was serially diluted and aliquots mixed with 
an  equal  volume  of 1WHF immune  serum,  and  as  controls,  additional  samples were mixed 
with normal inactivated horse serum.  Aliquots of the mixtures were incubated at room tem- 
perature for 1 hour; and at room temperature for 1 hour, followed  by incubation at  --20°C. 
for ,5 days. The mixtures with normal horse serum gave the same 50 per cent virus end-point 
under both of these conditions of incubation  (10  -8"I and  10-8'2).  Similarly,  the 50 per cent 468  n~fUNOLOGICAL REACTIONS  OF  COXSACKIE  VIRUSES.  I 
virus end-point was the same, under these conditions, in the presence of the undiluted immune 
serum (< 10-2). The difference between the negative logarithms of the 50 per cent virus end- 
points obtained in immune and normal serum was >  6.1 when incubated at room temperature 
for 1 hour, and >  6.2 when incubated at room temperature for 1 hour, followed by incubation 
at --20°C. for 5 days. Similar results have been obtained on the stability of other strains un- 
der these conditions. 
TABLE IV 
Effect of Time and Temperature on the Neutralimtion Index 
Temper-[  Time 
ature 
I 
hrs. 
Room  1 
--20  °  120 
NHF-i3m2 vkus 
Plus immune serum  Plus normal inactivated serum 
i 
10  -~ ilO~ 
i 
i 
0/80/6 
0/80/8 
riter 
Neg- 
10-4 I0-6  lOS !  stive  1.7 
ID~ 
o/8 0/8 0/8 ~ <2 
<2 
lO-S 
8/8(8) 
7/7 (7) 
lO"s 
717(7) 
8/8(7) 
10  ~  10  ~  10  ~ 
8/8 (8) 4/8 (3) 1/8 (0) 
6/6(5) .5/8(2) 0/8 
[Titer 
Neg- 
ative 
: IDso 
8.1 
8.2 
Log 
neu- 
trali- 
zation 
index 
>6.1 
>6.2 
TABLE V 
Effect of Route of Inoculation on Serum Neutralization Titer 
Route of inoculation 
Hi.Pt. strain  at concentration  of  10  -6 plus 
Human serum NC-77B (final  dilution)  Serum titer 
1:10  1:100  1:1000 
Intraabdominal  2/5 (0)  2/5 (0)  16/16 (7)  100 
Subcutaneous  0/8  2/8 (2)  6/6 (2)  100 
Control horse serum (1:  I0) plu~ 
Hi,Pt. virus at concentration of  Virus titer 
Negative 
log of ID~ 
101  10-'7  10"I  I0  "~ 
Intraabdominai  8/8 (7)  4/5 (0)  3/9 (3)  0/8  7.7 
Subcutaneous  8/8 (8)  8/8 (7)  7/9 (6)  0/8  8.3 
Effect  of the Route of Inoculation  on Serum Neutralization  and  Virus  End- 
Points.--It  appears  from Table  V  that  equally  good neutralization  can  be 
demonstrated if the serum-virus mixtures  are  inoculated  intraperitoneally  or 
subcutaneously. Human serum NC-77B, when mixed with approximately  100 
IDa0 of the High Point strain gave a serum titer of 100 when injected by either 
route.  The subcutaneous route of injection gives occasional virus  titers  1 log 
higher  than  by  the  intraperitoneal  route,  particularly  with  the  Ohio  strain 
(Table VI). In view of this fact, and also because the inoculum is less apt to 
leak following the latter route of injection, we use as a routine the subcutaneous 
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Effect of Complement.--To  determine  whether  complement played  a  role in 
the  in  vitro  phase  of  the  neutralization  test,  the  following  experiment  was 
conducted. 
Convalescent serum obtained from a patient 1 month after an acute illness characterized 
by fever, weakness, and abdominal pain and  by isolation of a  Conn.-5 type of C virus was 
used. Preliminary results using undiluted sera and serial tenfold dilutions showed that serum 
taken I month before illness contained no detectable antibodies to the Conn.-5 strain, whereas 
TABLE VI 
Effect of Route of Inoculation on Virus End-Point  Titer 
Route of inoculation 
Intraabdominal 
Subcutaneous 
Texas-1 
(a) 7.4 
(b) 7.9 
(a) 7.s 
(b) 7.9 
Negative log of ID~o of following  virus strains 
Hi.Pt.  Conn.-5 
7.7  5.9 
8.3  6.7 
Ohio-t 
(a) 5.9 
(b) 5.4 
(a) 7.2 
(b)6.5 
TABLE VII 
Lack of Effect of Complement in C Virus Neutralization  Test 
100 IDw doses of Conn.-5 strain were present in each serum dilution. 
Convalescent human serum 
Unheated 
Heated at 56  ° for 30 min. 
Unheated 
Heated at 56  ° for 30 rain. 
Final dilution of human serum 
(Virus suspended in unheated guinea pig serum) 
1:16  1:~  1:256 
o/7  o/8  o/lo 
o/8  Io/8  j  ~/8(o) 
(Virus suspended in heated guinea 
1/9(0)[1/8(0)11/7(0) 
0/9  0/9  0/6 
1:1024 
8/9 (6) 
8/9(5) 
,ig serum) 
6/8 (4) 
6/6(2) 
Serum titer 
256 
256 
256 
256 
serum drawn 6 weeks after illness neutralized 4 logs of virus (neutralization index of I0,000). 
The following experiment was carried out with the convalescent serum. 
The Conn.-5 strain was diluted to 2 ×  10  -4 concentration using as a diluent fresh guinea 
pig serum for one sample and heat-inactivated (56  ° for 30 minutes) guinea pig serum for the 
second. Equal volumes of these virus dilutions were mixed respectively with equal volumes 
of varying dilutions of the unheated  and heated  (56  ° for 30 minutes)  convalescent serum. 
Mter an incubation period of 1 hour at room temperature,  the mixtures were tested for in- 
fectivity as shown in Table VII. 
It  can be seen  that  complement  had  no effect on  the serum  neutralization 
titer,  which  was  found  to be 256  in  the  absence  as well as in the presence  of 
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Effect of Heat on Neutralizing  Antibodies.--To  determine whether or not the 
virus-neutralizing substances present in human serum were heat-labile,  titra- 
tions of various sera, before and after heating, were carried out against different 
strains of the virus. First a series of tests were performed in which several posi- 
TABLE VIII 
Resistance of C Virus Neutralizing Antibodies in Human Sera to 56°C.  for 30 Minutes 
Patient 
Cla. 
Fre. 
Mel. 
"ROW  , 
Cur. 
Bru. 
Fru. 
Hud. 
Mac. 
Sha. 
Bot. 
Area  Date  Strain 
Titer against 100 IDsB 
Maryland 
Maryland 
Maryland 
Ohio 
Ohio 
Ohio 
Ohio 
Ohio 
Ohio 
Conn. 
Conn. 
11/10/47 
1/12/48 
10/21/47 
12/ 4/47 
10/31/47 
12/ 4/47 
9/18147 
9/17/47 
8/28/47 
9/24/47 
8/24/47 
8/25/47 
9/22/47 
8/25/47 
9/22/47 
2/21/49 
8/25/48 
t/ 8/49 
Hi.Pt. 
Hi.Pt. 
Hi.Pt. 
Ohio-1 
Ohio-I 
Ohio-I 
Ohio-1 
Ohio-I 
Ohio-1 
Conn.-5 
Conn.-5 
Unheated 
100 
10 
100 
<I00 
10 
I0 
50 
250 
50 
>250 
5O 
250 
25O 
0 
0 
250 
0 
100 
56  ° for 30min. 
100 
10 
I00 
I00 
10 
10 
250 
250 
5O 
1250 
50 
25O 
250 
0 
0 
250 
0 
100 
tire human sera were titrated against 100 IDs0 doses of the High Point and Ohio 
strains  of virus, before and after they were heated at 56°C.  for 30 minutes. 
Non-specific inhibitors  to  a  variety of viral  agents  have  been  shown to  be 
destroyed at this temperature (12,  13). The results shown in Table VIII indi- 
cate that the neutralizing antibody to C virus in human sera is stable at 56  ° 
C. for 30 minutes. 
Further  experiments  were conducted to determine  the heat lability of the 
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For this purpose,  convalescent sera were selected from patients from whom C  virus had 
been recovered during their acute illness,  using in the neutralization tests a  strain of virus 
related to that isolated from the patient. In addition, a  chimpanzee serum was studied, oh- 
mined from an animal following three  serial infections with three  different immunological 
TABLE IX 
Heat Inactivation of Neutralizing Antibody  to Four Immunological Types of C Virus 
ViruS* 
Easton-2 
rexas-I 
Conn.-5 
Dhio-1 
Semmanddilu~on~ 
Serum held for30min, at  foHowlng 
temperatures 
56 °  60 °  65"  70 °  75 °  80 ° 
Patient AG 12/7/49 
1:s  o18  )IS  818(8) 8/8(8 8/8(8: 
1:40  0/8  D/8  5/5(2) 6/6(6) 
1:200  8/8(81 V8(8)  ~/8(8) 
Patient BA 10/5/49 
1:4  0/8  V8  I/7(0)  0/8  3/8  0/8  8/8(8; 
I: 40  0/8  3/8  1/7 (0) 0/8  3/8  5/7 (5) 
1: 400  (3/8  3/8  0/8  0/6  ~/8 (2) 
Patient G.J. 8/9/49 
1:8  o/8  OlS  !o/8  s/s(8)  8/8(6~ 
1:4o  o/8  o/8  ~/8(1) 
1:200  0/8  0/8  717(3) 
Chimp. Donna 12120/49 
1:12  0/8  0/8  D/8  0/8  1/7(0) 8/8(8) 9/9(3) 
1:120  0/8  0/8  0/8  0/7  10/8  9/9(9) 
1:1200  8/8(4) 8/8(2) 6/6(6) 7/7(5)  ~/8(1) 
Chimp. Donna 12/20/49 
1:12  0/8  0/8  019  0/4  [017  5/6(1) 6/6(5) 
1:120  0/8  0/8  1/7(0) 1/5(1) 4/8(3) 9/9(5) 
1:1200  8/8(4) 7/7(1) 7/7(1) 8/8(3) 8/8(3) 
Chimp. Donna 12/20/49 
I:12  0/8  0/8  Inc.  0/8  2/8(1) 7/7(4) 8/8(7) 
1:120  0/8  0/8  3/7  1/8(1) 8/3(2) 8/8(6) 
1:1200  8/8(4) 8/8(11 ~/8(2) 8/8(2) 8/8(2) 
Maximum 
temperature 
to maintain 
"~  Some 
"~  ~  Full  ac- 
~  titer  tiv- 
ity 
40  >56"  <70 ° 
>400  65"  750 
>200  >56  °  70 e 
120  70  °  70 e 
120  65"  70  ° 
120  65  °  70" 
* 100 ID60 of each virus, as indicated, was used in each serum mixture. 
~t Patients AG and BA had been infected with Easton-2 virus in September, 1949. 
Patient GJ had been infected with Texas-1 virus in July, 1949. Chimp. Donna had been infected with Conn.-5 
virus in March, 1949; with Texas-1 virus in May, 1949; and with Ohio-1 virus in October, 1949. 
types of C virus (Texas-l, Conn.-S,  and Ohio-l). The heat stability of the neutralizing anti- 
body to each strain in this serum containing multiple antibodies, as well as in the convalescent 
human sera, was studied by heating the sera for 30 minutes at the following temperatures: 
56  °, 60 °, 65 °, 70  °, 75 °, and 80°C. Then the serum fiter of the unheated serum was compared 
to that obtained with the heated serum, using 100 IDs0 doses of virus. 
The results in Table IX  illustrate  the stability of the neutralizing  antibody 
to four immunological types of virus. With low titered sera  (1:40 or less),  the 472  IMMUNOLOGICAL  REACTIONS  OF  COXSACKIE  VIRUSES.  I 
titer was maintained at 56°C.; all detectable  antibody was destroyed at tem- 
peratures at 70 °  (or less). With sera having titers above  1:120,  the antibody 
was not altered at 65 ° and had to be heated to 75 °, and in two instances (only 
one is  illustrated  in  the  table)  in  which the  serum titers  were above  1:400, 
the serum had to be heated to 80  ° before the antibody was no longer detectable. 
TABLE  X 
Effect of Virus Concentration upon Serum Titer 
Serum 
Convalescent 
human 
Convalescent 
human 
Convalescent 
mouse 
Convalescent 
mouse 
Convalescent 
mouse 
Hyperinunune 
mouse 
Hyperimmune 
hamster 
Hyperimmune 
Serum titers at following virus  Log serum titers with following 
Virus  ~  dilutions  logs of virus 
"r, 
.....  ! ....  i ..... 
E-2 m2  7X 5~0511  250 125C  It >12501  1,'~  2.4  3.1  3.1  >3.1 
NHF-'43 m:t 6.5  10C  /  2  2  3 
NHF-'43 m4 8.5  <IC  }  100 100  <1  1  2  2 
Texas-1 nl~  8.C  )  ' 10 100  l  1  2 
Conn.-5 m7  6.5 >1000 >1000  >3  >3 
Conn-5 m7  6.5  100  1000  :  2  3 
Conn.-5 m7  6.5  10  1001  1  2  I 
Quantitative  Antibody-Virus  Relationship.--To  determine  this  relationship, 
different  series  of  neutralization  tests  were  performed  with  human,  mouse, 
monkey, and hamster anti-sera with  their homologous C  virus  strains.  Both 
the quantity of serum and the quantity of virus were varied with respect to 
each  other  in  order  that  the  quantity  of serum required  to  neutralize each 
dilution of virus could be determined. The quantity of virus neutralized by the 
various amounts of serum in a particular series was calculated from the virus 
titration, which was done at the same time. 
On the basis of results in Table X,  it appears  that the neutralization of C 
virus strains does not give a straight line relationship between serum titer and ~'OSF.PH  L.  MELNICK  AND  NADA  LEDINKO  473 
quantity of virus neutralized.  However,  as the quantity of virus is increased, 
the quantity of serum required for neutralization likewise increases,  but for a 
uniform increase  in  the  quantity  of virus,  the  serum  titer  was  not found to 
decrease  in  similar  uniform  fashion,  as  has  been  reported  for  other  viruses 
(14, 15). 
Dissociatiort of the Virus-Antibody Complex.--To determine whether neutral- 
ized mixtures  of the virus  could  be made  infective  by dilution,  as  was  first 
shown by Andrewes for the pox viruses  (16),  the following experiments  were 
performed. 
TABLE XI 
E~ect of Dilution on Dissociation of Antigen-Antlbody Complex 
Texas-I strain plus  Texas-I strain plus saline  Concentration  of infected tissue  Texas immune serum* 
10-~ 
10  ~ 
10-= 
10  ~ 
10-6 
10-s 
10-7 
10-8 
0/4O 
0/24 
16/32 (16) 
29/32 (12) 
18/32 (13) 
1/29(0) 
1/29(0) 
0/32 
8/S (8) 
8/S (3) 
16/16(8) 
12/16(6) 
1/16(0) 
* A  10 per cent suspension of carcass infected with the Texas-1 strain was incubated with 
undiluted homologous Texas antiserum for 1 hour at room temperature and the virus-serum 
then diluted.  The original mixture is designated at  10  -~. 
A 10 per cent suspension of carcasses infected with the Texas-1 strain was mixed with an 
equal amount of undiluted  Texas monkey hyperimmune serum and incubated  for 1 hour at 
room temperature.  This was designated as 10  -1  , and the mixture was then diluted with saline 
in a series of tenfold dilutions to 10  -s. Each dilution was injected into infant mice. At the 
same time, the virus suspension was incubated with saline under the same conditions, diluted, 
and 10  ~  to 10  -s concentrations  of this  control  injected.  Previous  experience showed that 
higher concentrations of the virus were invariably fatal for mice. The results of two duplicate 
experiments have been combined and are listed in Table XI. 
Complete protection of the  10  -1 virus was afforded by undiluted serum and 
the  mixture  remained  non-infective  following  a  tenfold  dilution.  However, 
the virus  was infective when  the mixture  was diluted  100,  1000,  and  10,000 
times  designated as  10-3,  10  -4  ,  and  10  -5 concentrations  of virus in the table. 
At the  10  -6 and  10-  7 concentrations,  containing 20 and  2 IDs0 doses of virus 
respectively,  and serum concentrations of 10-  5 and  10  -e,  the virus  was again 
non-infective.  It would appear  that  at  this  level of virus,  traces  of antibody 
were sufficient to neutralize again this small amount of virus, or that two logs 
of virus had been destroyed.  By titrating  the virus in the presence of tenfold 474  I'~MIYNOLOGICAL REACTIONS  OF COXSACKIE  VIRUSES. I 
dilutions  of serum  such  as  were present  in  the  diluted  mixture,  (i.e.,  10  °05 
infected tissue plus an equal volume of 10  -~ immune serum, 10  -8 infected tissue 
plus 1000" serum,  1000  7 infected tissue plus 10  --e serum, etc.), it was shown that 
such traces of serum were incapable of  influencing the virus titer. Thus  al- 
though neutralized virus-serum mixtures may be reactivated by simple dilution, 
some  of the virus is  rendered irreversibly non-infective. 
Antigenic  Typing  of Strains.--Specific  neutralizing antibody is  one of the 
most widely used reagents for identifying different antigenic types of a virus, 
and for the C group of viruses this statement also holds true. For strains be- 
Serum  Neutralization  Titer  Following  Infeotlon  with 
C  Virus 
1250, 
250. 
E 
o  50. 
!  5  5  28 
Days  Days 
(Ohio Strain) 
.2" 
.°. 
!.:, 
.'..: 
3 
Months 
Time  after  onset 
2~ 
Years 
FIG.  1.  Duration of antibodies following infection with the Ohio-1 strain. Three patients 
are represented on the chart by the black, dotted, and white columns respectively. Virus was 
isolated from each patient at the time the first serum samples were obtained. 
longing to one antigenic type, such a  relationship may be established either 
by using a  typed virus with a  serum to an unknown type or vice versa. Two 
experiments  with  strains  isolated  in  two  epidemic  areas  (Ohio,  1947,  and 
Easton, Pennsylvania, 1949) serve to illustrate the reciprocal crossing between 
strains belonging to a  single type. The results, listed in Table XII, illustrate 
that strains isolated from different patients in an area may belong to a single 
type, but that the two types shown differ from each other. 
Further  experiments in  strain  classification in  which varying dilutions of 
virus have been set up against undiluted immune sera are summarized in Table 
XIII. We now recognize at least seven different immunological types? 
1 Dr. Gilbert Dalldorf kindly supplied us with his 3 antigenic types referred to in Tables 
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Antibody Devdopment in Relation to Human Disease.--The available evidence 
suggests  that  neutralizing antibodies to  different strains of  C  virus develop 
early in the course of the disease (1, 4). Further information on the specificity 
of  the  neutralizing antibody response has  been obtained from  an extensive 
TABLE XlI 
Cross-Reactions of Homotypic Strains 
Virus 
Ohio-I 
Ohio-2 
Ohio-3 
Easton-2 
Easton-6 
Easton-18 
Control  IDe  [ 
Ohio-t 
10  -~a  >4.2 
10  -4.4  >3.4 
i0-~  a 
I0  -s'+  0 
lO-e.o 
10-6 .a 
Log of neutralization index of immune serum 
Ohio-_._  2~2 Ohio-_____~ 
>4.2  I  >4.2 
>3.4  {  >3.4 
>3.7  >3.7 
Easton-2 
0 
>4.5 
>4.0 
>4.3 
Easton-6 
>4.5 
>4.0 
Easton-18 
>4.5 
>4.3 
TABLE XlII 
Cross-Neutralization of Strains of C Virus and Demonstration of Seven Antigenic Types 
Virus 
Coln.-5 
Ohio-1 
Texas-I 
Hi.Pt. 
NHF-'43 
Easton-2 
NY-5 
Dalldorf  1 
Dalldorf  2 
Dalldorf  3 
Nancy 
Control  ][De 
10--$ .T 
l0 s.9 
10-7.o 
10-s.s 
10-7.6 
10-s.o 
10  ~.+ 
i0-+.o 
10-+ 
I0--+ 
lO's 
Coni1. 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Immune serum: Log of neutralization index 
Ohio 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Texas  Hi,Pt.  Easton 
0  0  0 
0  0  0 
6.0  5.0 
4.6  5.0 
6.0  6.0 
0 
0 
0 
0 
0 
0 
0  0 
0  0 
0  0 
0  5.0  5.0 
0  >4.5  >4.5 
0  5.0  5.0 
0  0  I  0 
0  0  J  0 
0  0  0 
D-I  D-2  D.3 
0  0  0 
0  0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
o 
0  0 
I Nancy 
0 
study  of  the  occurrence  and 
contracted infections with one 
them in the laboratory (17). 
development 
or another of 
of  antibodies in 6  patients  who 
the C  viruses while working with 
From each patient a virus was isolated during the acute phase of illness which was typed 
by following the reactions with specific hyperimmune animal sera (see bottom three rows of 
Table XIV). The data in Table XIV also show that no patient before his illness had detecta- 
ble antibodies to the strain subsequently isolated from him or to the prototype  strain. But 
soon after illness, there developed simultaneously antibodies to the strain isolated from the 
patient and to the prototype  strain to which it was related. 
The reactions of the sera of the laboratory patients with strains not related to the one iso- 476  IMMUNOLOGICAL REACTIONS OF COXSACKI]~ VIRUSES,  I 
TABLE XIV 
Antibody Response in 6 Patients Infected While Working with C Viruses 
Patient and date 
of  onset 
EWS 
1/9/49 
JLM 
5/16/49 
NL 
5/21/49 
LMK 
lO/2O/49 
FL 
7116149 
GJ 
7/6/49 
M~aal immune 
Serum 
1/11/49 
2/21/49 
3/25/49 
11/29/48 
2/21/49 
5118/49 
5/26149 
6/12149 
10/20/49 
2/10/49 
5/26/49 
11/ 2/49 
3/25/49 
5/24/49 
lO/28/49 
12/27/49 
6/15/49 
7/25/49 
6/15149 
7/25/49 
Conn, 
mouse 
lO/2O/49 
Texas, 
mouse 
10/22/49 
0hio, 4332 
8/11/49 
Serum titer obtained against I00 ID~ of virus 
Virus strain used in neutralization test 
~S 
ml* 
0 
50 
250 
LK mt FLmt  Conn.-$ Texas-1  Ohio m:  JLMmt  NLml  GJml[  me  m4 
0  0  0 
100  I00  0 
IO0  0 
0  I  0  0  100 
0  I  0  100  10 
0  0  100  100 
250  100  100  1000 
1250  100  loo  loo 
100  100  lOo 
0  0  0  100 
125C  100  100  100 
1000  100  100 
(  10  10  0 
0  10  1000  0 
100  1000  100  100 
100  1000 
C  0  0  0 
100[  0  XOO0  0 
0  0  0  0 
250  0  100  0 
>100 >100' >100  C  0  0  1000  0  0 
0  0 
0  0 
0  O!>lO0 >lOG  0  1000  0 
0 > 100'  0  (J  0  0  1000 
* Subscripts after letter m  indicate the number of passages the virus had undergone in 
mice before it was used in the neutralization tests. 
lated from each patient are instructive. Only 2 of the 6 patients had an illness due to Texas 
type infection, yet the other 4 must have had a subclinical infection with this type. The re- 
sults with the serial samples of blood taken from patient JLM starting several months before 30SEPH  L.  MELNICK  AND  NADA  LEDINKO  477 
his illness emphasize this point: On November 29, 1948,  antibodies were absent to both the 
Conn. and Texas types. By February 21, 1949,  antibodies to the Texas type had appeared 
in fiter of 1 : 100 and this serum level was maintained in the next 4 bleedings carried out in 
May, June, and October of that year. The patient became ill (diagnosis compatible with epi- 
demic pleurodynia or myalgia) on May 16 at a  time when he had no antibodies to his own 
strain or to the Conn. prototype. By May 26, such antibodies were present. 
TABLE  XV 
Family Infection with Two Types of Coxsachie Virus 
Serum titer obtained agianst 100 ID,s of virus 
Serum 
N ~I mt  SM 1 a  I  Conn.-5 ms  Texas-I m4  0hio-1 ms 
JLM*  2/21/49 
5/18/49 
5/26/49 
6/12/49 
NM  3/23/49 
6/ 3/49 
SM  6/3/49 
12/29/49 
Conn.-5 
Texas-1 
Ohio-1 
Dalldorf-1 
DaUdorf-2 
Dalldorf-3 
0 
0 
250 
1250 
0 
0 
0 
0 
>1~ 
0 
0 
0 
0 
0 
25~ 
25q 
0 
51 
0 
0 
0 
0 
0 
0 
0 
0 
L~ 
0 
0 
100 
100 
0 
0 
0 
0 
1000 
0 
0 
0 
0 
0 
100 
100 
100 
100 
250 
250 
250 
250 
0 
1000 
0 
0 
0 
0 
10 
100 
1000 
100 
0 
0 
0 
0 
0 
0 
1000 
0 
0 
0 
* JLM had fever from May 18 to May 23. NM had fever from May 14 to May 16 and 
recurrence on May 27 and 28. 
Concerning antibodies to the Ohio type, 2 patients had such antibodies before they became 
ill (to a heterolognus type). Three of the remaining 4 persons did not develop Ohio antibodies 
during the period studied, whereas a  fourth, LMK,  did--at the time of illness. The LMK 
strain proved to belong to the Ohio type. 
At the time of JLM's infection with the Conn. type, his family was infected with yet an- 
other type. His daughter, Nancy aged 8, was iU with 2 bouts of fever (maximum 103.5°),  the 
first from May 14 to 16 and the second from May 27 to 28. Virus was isolated from fecal sam- 
ples collected May 21 and June 5. Her strain belonged to a  hitherto unknown type, shown 
by the data in Table XV. Nancy's mother was a healthy carrier of this strain as evidenced by 
isolation of the virus from her stools collected on June 10. However, unlike Nancy, she did 
not develop neutralizing antibodies to her own virus, nor to the Conn. type which was the 478  IMMUNOLOGICAL  REACTIONS  0F COXSACKIE  VIRUSES. I 
causative agent of her husband's illness. Nancy developed antibodies to her own virus, to her 
mother's virus, but not to her father's virus. Between May 18 and 26, her father developed 
antibodies not only to his virus and to the Conn. type to which it was related, but also to the 
type which infected  the other two members of the family. The only reason for interpreting 
his illness as due to the Conn. type and not to Nancy's type was the isolation of a Conn. type 
virus during his illness. Actually, strains isolated early in his disease (stools of May 19) and 
late (throat swab of May 31) were typed and both belonged to the Corm.-5 type. 
Duration of Neutralizing Antibodies in Man and Their Occurrence in Normal 
Populations.--In order to attempt an answer to this question 3 patients, proven 
to be infected with C virus by means of virus isolation plus antibody responses 
(4),  were followed for a  period of over 2  years.  2 The  data of Fig.  1  indicate 
that neutralizing bodies appear early (by the 5th day of onset), increase rapidly 
to titers of  1:1250 which are maintained during the period of 1 to 3  months 
following infection, and may still be present 2  years later, although at lower 
levels (titer of 1:50 to  1:250).  Studies with strains belonging to other types 
have not been as extensive, but  fit  into  the  same  pattern. The  frequency  of 
the finding of neutralizing antibodies in normal adult human sera and gamma 
globulin also supports the view that these antibodies persist for long periods. 
The largest series in this study is concerned with over 200 children in Winston-Salem~ 
North Carolina, who were bled in May, 1948, and again 6 months later. During this period, 
an epidemic of poliomyelitis  occurred in the area, having its peak incidence in July. Antibody 
tests were carried out with the High Point strain, isolated from a sample of urban sewage 
collected in July of that year from High Point, a small city about 20 miles from Winston- 
Salem. All sera were inactivated at 56°C. for 30 minutes before use. Serum dilutions were set 
up against 100 ID60 doses of virus. It was soon discovered that when antibodies were present 
the serum titer was over 10 and usually about I00. When a serum dilution of 10 was negative, 
the undiluted serum was usually also negative. Consequently,  in Fig. 2 we have plotted the 
percentage of sera with titers of 10 or over. From the determinations on 20 placental sera, it 
was found that a high percentage of children start life with antibodies to this C strain. The 
level falls rapidly to a minimum of 14 per cent positive at the age of 1, and then it quickly 
rises to reach the adult level of 80 per cent at the age of 7. It is of interest that a sizable num- 
ber of healthy children who were devoid of antibodies in May developed them by November. 
The relationship of these antibody levels, and changes in them during the summer, to other 
antibodies forms the subject of another report (18). 
Neutralizing antibodies to specific types may occur in certain normal popu- 
lations as shown by the finding in one area that 60 normal sera all contained 
antibodies to the Texas-1  type but not  to  the Conn.-5  type. That  the latter 
strain is not localized to the state in which it was isolated in 1948, is suggested 
by its crossing with a  strain isolated in Winston-Salem, North Carolina, and 
by the finding of antibodies to the Conn. strain in adults in Sweden. Further- 
more, gamma globulin collected in different parts of this country and in Den- 
mark has  been  found  to  contain  antibodies to  at least four  antigenic  types 
of C virus (Table XVI). 
We are indebted to Dr. Albert B. Sabin for making these scra available to us. JOSEPH  L.  MELNICK  AND  NADA  LEDINKO  479 
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FIO. 2. Neutralizing antibodies in the normal population  of Winston-Salem, North Caro- 
lina, in  1948. The white  columns represent  samples collected in the spring and the black 
columns, samples from the same persons collected in the fall. 
TABLE  XVI 
Titer  of Gamma Globulin Samples against Four Different Antigenic  Types  of C  Virus 
Year 
1944 
1945 
1945 
1945 
1949 
1949 
Area 
Northeastern United States 
Eastern United States 
Central United States 
Western United States 
Eastern United States 
Denmark 
Titers obtained with 100 ID~ virus 
Conn.-S ~17 i 
>64 
Hi,Pt, ms 
lOO 
lOOO 
lOO 
too 
lOOO 
>1ooo 
Easton-2 m~ 
1oo 
lOO 
IOO 
1oo 
Ohio m 
DISCUSSION 
In the course of work with the new group of Coxsackie viruses,  it became 
necessary  to  develop  reliable  tests  for  neutralizing  antibodies  in  order  to 
proceed with  the  typing of new strains  and  to  obtain  some insight  into  the 
immune response in man.  Certain of the variables inherent in such tests have 
been  investigated,  such  as  effects  of  time,  temperature,  complement,  and 
route  of inoculation  of test  mice. 
Several  strains  of virus  have  been  typed.  At present  they fall  into  seven 480  IMM'ITNOLOGICAL REACTIONS 01  ~ COXSACKIE VIRUS]ES. I 
distinct immunological types, three of which have been isolated and previously 
typed by Sickles and DaUdorf (19). Certain types may be widespread in a par- 
ticular period.  For example  the  Conn.-5  type in 1947 and 1948 was present 
in eastern United States,  having been recovered from patients and sewage in 
Connecticut, from patients and flies in North Carolina (5), and from patients in 
Boston (20) and New York City (21). It is noteworthy that this virus type was 
isolated  from cases  of epidemic myalgia (epidemic pleurodynia, Boruholm's 
disease)  (20-22). Recently in Britain,  Findlay and  Howard (23) have con- 
firmed  these  findings, having produced infectious  myalgia by intranasal in- 
stillation of the Type 2 virus in a human volunteer, and having isolated a C 
virus (untyped) from a naturally occurring case. 
Another type which has appeared in widely scattered areas is the Texas-1. 
Originally isolated from flies trapped in the Rio Grande Valley, this type of 
virus has been recovered from "poliomyelitis" patients in Texas, from sewage 
in North Carolina  (High Point strain), and from files trapped in Connecticut 
in  1943. Serological evidence points to the widespread  occurrence  in North 
America and in Europe of this type as well as other types. Furthermore, gamma 
globulin  collected between 1944 and  1949 from several  areas  in the United 
States as well as in Denmark has been found to contain antibodies  to the 4 
types arbitrarily selected for testing. 
Although a single type may predominate in a  given area,  it has been  our 
experience in three poliomyelitis epidemic areas to find more than one immuno- 
logical type of virus in the population. This has been true of the epidemics in 
1948 in Texas and in North Carolina  and in 1949 in East  on,  Pennsylvania. 
It is of interest that two antigenic types of virus were isolated from one family. 
However  the exposure of this family was unusual in that one member was 
actively engaged in laboratory work in the C viruses. 
The six infections  which occurred  in laboratory workers  at Yale---as  well 
as the infections reported among British workers--serve as good illustrations 
of the specificity of the response, each patient responding in a matter of days 
with antibodies  to  the  strain isolated from his intestines or  throat. These 
experiences serve as an accidental but nonetheless fine example that strains be- 
longing to the Conn.-5, Ohio-l, and Texas-1 types can cause disease in man. 
To these should be added the Type 2 virus in light of the British work (23) 
with human volunteers. 
SUMMARY 
The neutralization test is a reliable and useful procedure for following immun- 
ological reactions of the Coxsackie viruses (C virus). 
The standard procedure  has been an incubation period of 1 hour at room 
temperature followed by subcutaneous inoculation  into newborn  mice. How- 
ever,  this time and temperature are not critical,  for the virus in neutralized 
within 10 minutes of mixing with immune serum and remains neutralized for ~OSEPH L. MIELNICK AND  NADA  LEDINKO  481 
long periods. During  the variable incubation periods used,  the control virus 
remained active, even in dilute suspensions. 
The neutralization test is not affected by the presence or absence of comple- 
ment. 
Neutralizing antibody is stable at 65°C. for 30 minutes, and immune serum 
has to be heated to 80°C. for 30 minutes before the antibody is no longer de- 
tectable. 
As  the  quantity of virus is increased,  the  quantity of serum required for 
neutralization likewise increases, but not in a regular or predictable fashion. 
Neutralized mixtures of the  virus  can be made  infective again by simple 
dilution before inoculation. 
The neutralization test is a satisfactory means for typing Coxsackie viruses. 
At  least  seven antigenic types have  been identified.  Similar antigenic types 
have been found to be scattered over wide areas. Thus the Conn.-5 type was 
present in 1948 in Massachusetts, Connecticut, New York, and North Carolina. 
The Texas-1 type was present in 1943 in Connecticut and in  1948  in  North 
Carolina  and Texas. 
Further information on the specificity of the neutralizing antibody response 
has been obtained from a  study of the occurrence and development of anti- 
bodies in 6 patients who contracted infections with one or another of the  C 
viruses while working with them in the laboratory. From each patient a virus 
was  isolated during  the illness.  No patient had  detectable antibodies  to his 
strain before his illness,  but each soon thereafter developed antibodies to his 
own strain and to the prototype strain to which it was related. 
By means of the neutralization test, it has been shown that a family epidemic 
may include two different immunological types of virus. 
Neutralizing antibodies appear at the time of or soon after onset of illness, 
increase rapidly to titers of about  1:1000 which  are maintained  during  the 
period of 1 to 3 months following infection, and are still present 2 years later, 
although at lower levels. 
Neutralizing  antibodies  are  present  in  the  normal  population.  In  North 
Carolina, over 80 per cent of the children have antibodies at birth. The level 
falls rapidly to a minimum of 14 per cent at the age of 1, and then it quickly 
rises  to reach the adult  level at  the age of 7.  Gamma  globulin  collected in 
various parts of the United States between 1944 and 1949 and in Denmark in 
1949 neutralizes at least four antigenically different Coxsackie viruses. 
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